𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Interleukin-2 induces cell cycle perturbations leading to cell growth inhibition and death in malignant mesothelioma cells in vitro

✍ Scribed by Camillo Porta; Marco Danova; Anna Maria Orengo; Silvano Ferrini; Mauro Moroni; Alessia Gaggero; Roberta Libener; Pier Giorgio Betta; Silvia Ferrari; Antonio Procopio; Luigi Strizzi; Luciano Mutti

Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
218 KB
Volume
185
Category
Article
ISSN
0021-9541

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interleukin-6 induces both cell growth a
Interleukin-6 induces both cell growth and VEGF production in malignant mesotheliomas
✍ Yasuo Adachi; Chieko Aoki; Naoko Yoshio-Hoshino; Koichi Takayama; David T. Curie 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 425 KB

## Abstract Malignant mesothelioma (MM), an incurable tumor, is reportedly an interleukin‐6 (IL‐6) secreting tumor. The pathological significance of IL‐6 overexpression in this tumor, however, has remained unclear. We investigated the biological functions of IL‐6 in mesotheliomas. Five mesothelioma

Poly(ADP-ribose) polymerase inhibitor in
Poly(ADP-ribose) polymerase inhibitor increases growth inhibition and reduces G2/M cell accumulation induced by temozolomide in malignant glioma cells
✍ Lucio Tentori; Ilaria Portarena; Francesco Torino; Massimo Scerrati; Pierluigi N 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 443 KB

## Abstract Temozolomide (TZM) is a novel methylating agent currently under investigation for treatment of recurrent high‐grade gliomas. Although TZM generates a wide spectrum of methyl adducts, its cytotoxicity has been attributed to mismatch repair (MR)‐mediated processing of O^6^‐methylguanine:T

Inhibition of PARP activity by PJ-34 lea
Inhibition of PARP activity by PJ-34 leads to growth impairment and cell death associated with aberrant mitotic pattern and nucleolar actin accumulation in M14 melanoma cell line
✍ Marta Chevanne; Michele Zampieri; Riccardo Caldini; Angela Rizzo; Fabio Ciccaron 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 482 KB 👁 1 views

## Abstract The capability of PARP activity inhibitors to prevent DNA damage recovery suggested the use of these drugs as chemo‐ and radio‐sensitisers for cancer therapy. Our research, carried out on cultured human M14 melanoma cells, was aimed to examine if PJ‐34, a potent PARP activity inhibitor